[1]
Singh, S.K. 2023. ASSESSING THE LEADER TRIAL: UNDERSTANDING MYOCARDIAL INFARCTION SUBTYPES IN TYPE 2 DIABETES MELLITUS PATIENTS AND THE BENEFICIAL IMPACT OF LIRAGLUTIDE THERAPY. Student’s Journal of Health Research Africa. 4, 12 (Dec. 2023), 5. DOI:https://doi.org/10.51168/sjhrafrica.v4i12.865.